Refractory anaplastic large cell lymphoma rescued by the combination of the second-generation alk inhibitor brigatinib, high-dose chemotherapy and allogeneic stem cell transplantation: a case report and review of the literature

HIGHLIGHTS

• who: Giulia Caddeo from the Pediatric Hematologyu2011Oncology, Department of Mother and Child, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy have published the research: Refractory Anaplastic Large Cell Lymphoma Rescued by the Combination of the Second-Generation ALK Inhibitor Brigatinib, High-dose Chemotherapy and Allogeneic Stem Cell Transplantation: A Case Report and Review of the Literature, in the Journal: (JOURNAL) of 31/07/2022
• what: The authors report the case of a 13-year-old boy diagnosed with stage IV ALCL refractory to first-line conventional chemotherapy and second-line therapy with the anti CD30 antibody . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.